Literature DB >> 8245789

Advanced glycosylation endproduct-specific receptors on human and rat T-lymphocytes mediate synthesis of interferon gamma: role in tissue remodeling.

F Imani1, Y Horii, M Suthanthiran, E Y Skolnik, Z Makita, V Sharma, P Sehajpal, H Vlassara.   

Abstract

During normal aging and in chronic diabetes the excessive accumulation of reactive glucose-protein or glucose-lipid adducts known as advanced glycosylation endproducts (AGEs) has been shown to induce tissue dysfunction, in part through interaction with AGE-specific receptors on monocyte/macrophages and other cells. Recognizing that circulating lymphocytes trafficking through tissues interact with tissue AGEs, we searched for the expression of AGE-binding sites on peripheral blood T lymphocytes. Resting rat and human T cells bound 125I-AGE-albumin with an affinity of 7.8 x 10(7) M-1, whereas, after stimulation with phytohemagglutinin (PHA) for 48 h, binding affinity increased to 5.8 x 10(8) M-1. Flow cytometric analysis of resting rat T cells using polyclonal antibodies raised against rat liver AGE-binding proteins (p60 and p90) revealed the constitutive expression of both immunoreactivities. The number of resting CD4+ and CD8+ T cells positive for anti-p60 antibody binding (34.2 and 58.5%, respectively) increased to 92 and 90% of cells after 48-h stimulation with PHA. Exposure of PHA-activated T lymphocytes to AGE-albumin enhanced expression of interferon gamma (IFN-gamma) mRNA 10-fold and induced greater elaboration of the mature protein than did exposure to unmodified protein or PHA treatment alone. These data indicate that T cells contain an inducible system of surface receptors for AGE-modified proteins, and that receptor occupancy is linked to lymphokine production. This T cell AGE-receptor system might serve to target lymphocytes to AGE-rich tissues and involve them in the regulation of tissue homeostasis either by assisting in macrophage-dependent clearance of AGE-proteins, or by exerting direct antiproliferative action on mesenchymal cells. Under conditions of excessive AGE-protein and AGE lipid accumulation (e.g., aging and diabetes), enhanced production of AGE-induced IFN-gamma may accelerate immune responses that contribute to tissue injury.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8245789      PMCID: PMC2191269          DOI: 10.1084/jem.178.6.2165

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  28 in total

Review 1.  Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions.

Authors:  P Libby; G K Hansson
Journal:  Lab Invest       Date:  1991-01       Impact factor: 5.662

2.  Atherosclerotic lesions in humans. In situ immunophenotypic analysis suggesting an immune mediated response.

Authors:  A C van der Wal; P K Das; D Bentz van de Berg; C M van der Loos; A E Becker
Journal:  Lab Invest       Date:  1989-08       Impact factor: 5.662

3.  Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging.

Authors:  M Kirstein; J Brett; S Radoff; S Ogawa; D Stern; H Vlassara
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

4.  Isolation of surface binding protein specific for advanced glycosylation end products from mouse macrophage-derived cell line RAW 264.7.

Authors:  S Radoff; A Cerami; H Vlassara
Journal:  Diabetes       Date:  1990-12       Impact factor: 9.461

5.  Gamma-interferon regulates vascular smooth muscle proliferation and Ia antigen expression in vivo and in vitro.

Authors:  G K Hansson; L Jonasson; J Holm; M M Clowes; A W Clowes
Journal:  Circ Res       Date:  1988-10       Impact factor: 17.367

6.  Interferon gamma inhibits both proliferation and expression of differentiation-specific alpha-smooth muscle actin in arterial smooth muscle cells.

Authors:  G K Hansson; M Hellstrand; L Rymo; L Rubbia; G Gabbiani
Journal:  J Exp Med       Date:  1989-11-01       Impact factor: 14.307

7.  Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties.

Authors:  C Esposito; H Gerlach; J Brett; D Stern; H Vlassara
Journal:  J Exp Med       Date:  1989-10-01       Impact factor: 14.307

8.  A novel addition to the T cell repertory. Cell surface expression of tumor necrosis factor/cachectin by activated normal human T cells.

Authors:  M Kinkhabwala; P Sehajpal; E Skolnik; D Smith; V K Sharma; H Vlassara; A Cerami; M Suthanthiran
Journal:  J Exp Med       Date:  1990-03-01       Impact factor: 14.307

9.  Human and rat mesangial cell receptors for glucose-modified proteins: potential role in kidney tissue remodelling and diabetic nephropathy.

Authors:  E Y Skolnik; Z Yang; Z Makita; S Radoff; M Kirstein; H Vlassara
Journal:  J Exp Med       Date:  1991-10-01       Impact factor: 14.307

10.  Two novel rat liver membrane proteins that bind advanced glycosylation endproducts: relationship to macrophage receptor for glucose-modified proteins.

Authors:  Z Yang; Z Makita; Y Horii; S Brunelle; A Cerami; P Sehajpal; M Suthanthiran; H Vlassara
Journal:  J Exp Med       Date:  1991-09-01       Impact factor: 14.307

View more
  25 in total

1.  Elevated AGE-modified ApoB in sera of euglycemic, normolipidemic patients with atherosclerosis: relationship to tissue AGEs.

Authors:  A W Stitt; C He; S Friedman; L Scher; P Rossi; L Ong; H Founds; Y M Li; R Bucala; H Vlassara
Journal:  Mol Med       Date:  1997-09       Impact factor: 6.354

2.  Effects of advanced glycation end-products on the proliferation and differentiation of osteoblast-like cells.

Authors:  A D McCarthy; S B Etcheverry; L Bruzzone; A M Cortizo
Journal:  Mol Cell Biochem       Date:  1997-05       Impact factor: 3.396

Review 3.  New molecular insights in diabetic nephropathy.

Authors:  Ionel Alexandru Checheriţă; Gina Manda; Mihai Eugen Hinescu; Ileana Peride; Andrei Niculae; Ştefana Bîlha; Angelica Grămăticu; Luminiţa Voroneanu; Adrian Covic
Journal:  Int Urol Nephrol       Date:  2016-01-12       Impact factor: 2.370

Review 4.  AGE restriction in diabetes mellitus: a paradigm shift.

Authors:  Helen Vlassara; Gary E Striker
Journal:  Nat Rev Endocrinol       Date:  2011-05-24       Impact factor: 43.330

5.  Identification of galectin-3 as a high-affinity binding protein for advanced glycation end products (AGE): a new member of the AGE-receptor complex.

Authors:  H Vlassara; Y M Li; F Imani; D Wojciechowicz; Z Yang; F T Liu; A Cerami
Journal:  Mol Med       Date:  1995-09       Impact factor: 6.354

6.  Lymphocytes promote albuminuria, but not renal dysfunction or histological damage in a mouse model of diabetic renal injury.

Authors:  A K H Lim; F Y Ma; D J Nikolic-Paterson; A R Kitching; M C Thomas; G H Tesch
Journal:  Diabetologia       Date:  2010-04-27       Impact factor: 10.122

7.  NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X.

Authors:  J C Pickup; M B Mattock; G D Chusney; D Burt
Journal:  Diabetologia       Date:  1997-11       Impact factor: 10.122

Review 8.  Combating diabetic nephropathy with drug therapy.

Authors:  D Martins; K Norris
Journal:  Curr Diab Rep       Date:  2001-10       Impact factor: 4.810

9.  Glycation, oxidation, and lipoxidation in the development of the complications of diabetes: a carbonyl stress hypothesis.

Authors:  Timothy J Lyons; Alicia J Jenkins
Journal:  Diabetes Rev (Alex)       Date:  1997

10.  Impaired immune responses in streptozotocin-induced type I diabetes in mice. Involvement of high glucose.

Authors:  R Rubinstein; A M Genaro; A Motta; G Cremaschi; M R Wald
Journal:  Clin Exp Immunol       Date:  2008-09-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.